Human leucocyte antigen class II polymorphism in Irish patients with multiple sclerosis

Tissue Antigens

Volumn 68, Issue 3, 2006, Pages 257-262

  Dunne, C ^a   McGuigan, C ^b   Crowley, J ^a   Hagan, R ^a   Rooney, G ^a   Kelleher, J ^a   Hutchinson, M ^b   Lawlor, E ^a  

^a National Blood Centre Ireland   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Association; HLA class II; Irish; Multiple sclerosis

Indexed keywords

HLA ANTIGEN CLASS 1; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HAPLOTYPE; HOMOZYGOSITY; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IRELAND; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC;

EID: 33748428050     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00664.x     Document Type: Article

References (39)

1. Rothwell PM, Charlton D. High incidence and prevalence of multiple sclerosis in southeast Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998: 64: 730-5.
2. Giordano M, D'Alfonso S, Momigliano-Richiardi P. Genetics of multiple sclerosis. Am J Pharmacogenomics 2002: 2: 37-58.
3. Oksenberg JR, Barcellos LF, Hauser SL. Genetic aspects of multiple sclerosis. Semin Neurol 1999: 19: 281-8.
4. Oksenberg JR, Barcellos LF, Cree BAC et al. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am J Hum Genet 2004: 74: 160-7.
5. International Multiple Sclerosis Genetics Consortium. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005: 77: 454-67.
6. Kurtzke JF, Beebe GW, Norman JE et al. Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution. Neurology 1979: 29: 1228-35.
7. Robertson N, Compston A. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995: 58: 2-6.
8. Skegg DGG, Corwin PA, Craven PS, Malloch JA, Pollock M. Occurrence of multiple sclerosis in the north and south of New Zealand. J Neurol Neurosurg Psychiatry 1987: 50: 134-9.
9. Hammond SR, McCleod JG, Millingen KS et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 1988: 111: 1-25.
10. McGuigan C, McCarthy A, Quigley C, Bannan L, Hawkins SA, Hutchinson M. Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity? J Neuro Neurosurg Psychiatry 2004: 75: 572-6.
11. Swingler RJ, Compston D. The distribution of multiple sclerosis in the United Kingdom: J Neurol Neurosurg Psychiatry 1986: 49: 1115-24.
12. Poskanzer DC, Terasaki PI, Prenney LB, Sheridan JL, Park MS. Multiple sclerosis in the Orkney and Shetland Islands. J Epidemiol Community Health 1980: 34: 253-7.
13. Francis DA, Batchelor JR, McDonald WI et al. Multiple sclerosis in North-East Scotland. Brain 1987: 110: 181-96.
14. Poser CM, Paty DQ, Schienberg L et al. New diagnostic criteria for multiple sclerosis. Guidelines for research protocol. Ann Neurol 1983: 13: 227-31.
15. Yeh FC, Boyle TJB. Population genetic analysis of co-dominant and dominant markers and quantitative traits. Belg J Bot 1997: 129: 157.
16. Schneider S, Roessli D, Excoffier L. A Software for Population Genetics Data Analysis: Ver. 2.000. Geneva: Genetics and Biometry Lab, Department of Anthropology, University of Geneva, 2000.
17. Payami H, Nadir SJ, Farid R et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989: 45: 541-6.
18. Perneger TV. What's wrong with Bonferroni adjustments. BMJ 1998: 316: 1236-38.
19. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991: 38: 1-15.
20. Allen M, Sandberg-Wollheim M, Sjögren K, Erlich HA, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol 1994: 39: 41-8.
21. Luomala M, Elovarra I, Ukkonen M, Koivula T, Lehtimaki T. The combination of HLA-DR1 and DR53 protects against MS. Neurology 2002: 56: 383-5.
22. Laaksonen M, Pastinen T, Sjoroos M et al. HLA class II associated risk and protection against multiple sclerosis - a Finnish family study. J Neuroimmunol 2002: 122: 140-5.
23. Lindqvist AK, Lahdetie J, Tienari PJ et al. Mapping of the HLA class II susceptibility haplotype for multiple sclerosis in Finland. Hereditas 2000: 132: 89-94.
24. Spurkland A, Rønningen KS, Vandvik B, Thorsby E, Vartdal F. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum Immunol 1991: 30: 69-75.
25. Francis DA, Thompson AJ, Brookes P et al. Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ? Hum Immunol 1991: 32: 119-24.
26. Coraddu F, Sawcer S, Feakes R et al. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 1998: 2: 24-33.
27. Haegert DG, Swift FV, Benedikz J et al. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology 1996: 46: 1107-11.
28. Cullen CG, Middleton D, Savage DA, Hawkins S. HLA-DR and -DQ DNA genotyping in multiple sclerosis patients in Northern Ireland. Hum Immunol 1991: 30: 1-6.
29. McDonnell GV, Mawhinney H, Graham CA, Hawkins SA, Middleton D. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis. J Neurol Sci 1999: 165: 77-83.
30. Mallory JP, Ó Donnagháin B. The origins of the population of Ireland: a survey of putative immigrations in Irish prehistory and history. Emania: Bull Navan Res Group. 1998: 17: 47-81.
31. Weinshenker BG, Santrach P, Bissonet AS et al. Major histocompatibility complex class II alleles and the course and outcome of MS. Neurology 1998: 51: 742-7.
32. Gorodezky C, Najera R, Rangel BE et al. Immunogenetic profile of multiple sclerosis in Mexicans. Hum Immunol 1986: 16: 364-74.
33. Pina MA, Ara JR, Lasierra P et al. Study of HLA as a predisposing factor and its possible influence in the outcome of multiple sclerosis in the sanitary district of Calatayud, Northern Spain. Neuroepidemiology 1999: 18: 203-9.
34. Marrosu MG, Murru R, Murru MR et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001: 10: 2907-16.
35. Kwon OJ, Karni A, Israel S et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol 1999: 56: 555-60.
36. North KE, Martin LJ, Crawford MH. The origins of the Irish travellers and the genetic structure of Ireland. Ann Hum Biol 2000: 27: 453-65.
37. Dyment DA, Herrera BM, Cader MZ et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005: 14: 2019-26.
38. Harbo HF, Lie BA, Sawcer S et al. Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 2004: 63: 237-47.
39. Finch T, Lawlor E, Borton M et al. Distribution of HLA-A, B and DR genes and haplotypes in the Irish population. Exp Clin Immunogenet 1997: 14: 250-63.